The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer

Over the past 10 years, cancer immunotherapy has made significant progress in multiple cancer types and has been gradually been applied to clinical cancer care, in which the programmed cell death protein-1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is one of the most attractive targets. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Xin-wei, Jiang, Jian, Pang, Xin, Huang, Mei-chang, Tang, Ya-jie, Liang, Xin-hua, Tang, Ya-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531035/
https://www.ncbi.nlm.nih.gov/pubmed/33072064
http://dx.doi.org/10.3389/fimmu.2020.01721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531035/
https://www.ncbi.nlm.nih.gov/pubmed/33072064
http://dx.doi.org/10.3389/fimmu.2020.01721

Ejemplares similares